Prioritizing Fertility Care in Sickle Cell Disease Treatment
Researchers proposed that integrating standardized fertility care into SCD treatment is a requisite of high-quality, personalized care
Researchers proposed that integrating standardized fertility care into SCD treatment is a requisite of high-quality, personalized care
Researchers sought to determine whether rondaptivon pegol would be an effective treatment to increase endogenous FVIII levels in patients with hemophilia A.
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
A study sought to determine the effect of an antimicrobial stewardship team on carbapenem therapy in patients with hematologic disorders.
Few adverse events seen, even in prophylactic use.
Researchers sought to determine whether certain genetic variants would impact outcomes for patients with AML in first remission prior to undergoing allo-HSCT.
Researchers sought to determine whether magrolimab combined with azacitidine would be an effective treatment for patients with high-risk MDS.
A review of myelofibrosis, including an update on treatment options, was presented at the 2023 ONA Summit.
A review of MDS/MDN, including new WHO guidelines and collaborative strategies for managing the care of patients with lower-risk MDS.
Researchers sought to determine whether combination dabrafenib and trametinib would be effective in patients with relapsed/refractory HCL.